This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hughes, B. Antibody–drug conjugates for cancer: poised to deliver? Nature Rev. Drug Discov. 9, 665–667 (2010).
Lash, A. Antibody–drug conjugates: the next generation of moving parts. START-UP 27 Dec 2011 (Article #2011900259).
Seattle Genetics. 2012 press releases. Seattle Genetics website [online], (2012).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zolot, R., Basu, S. & Million, R. Antibody–drug conjugates. Nat Rev Drug Discov 12, 259–260 (2013). https://doi.org/10.1038/nrd3980
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3980
This article is cited by
-
Strategies for the enhancement of anti-cancer effect of phosphodiesterase type 5 inhibitors using drug binding fusion proteins
Biotechnology and Bioprocess Engineering (2024)
-
Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview
Drug Delivery and Translational Research (2022)
-
Bioengineering of microbial transglutaminase for biomedical applications
Applied Microbiology and Biotechnology (2019)